These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 9879331)

  • 1. [Resistance to antiretroviral agents: mechanism and study methods].
    Bossi P; Calvez V; Bricaire F
    Presse Med; 1998 Dec; 27 Suppl 5():18-9. PubMed ID: 9879331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
    Van Vaerenbergh K
    Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiretroviral drug resistance: mechanisms, pathogenesis, clinical significance.
    Richman DD
    Adv Exp Med Biol; 1996; 394():383-95. PubMed ID: 8815703
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Replication capacity, biological phenotype, and drug resistance of HIV strains isolated from patients failing antiretroviral therapy.
    Nicastri E; Sarmati L; d'Ettorre G; Palmisano L; Parisi SG; Uccella I; Rianda A; Concia E; Vullo V; Vella S; Andreoni M
    J Med Virol; 2003 Jan; 69(1):1-6. PubMed ID: 12436471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Discontinuation of antiretroviral treatment containing a protease inhibitor. Failure and tolerance].
    Michelet C
    Presse Med; 1999 Feb; 28(8):402-4. PubMed ID: 10093600
    [No Abstract]   [Full Text] [Related]  

  • 6. Baseline antiretroviral drug susceptibility influences treatment response in patients receiving saquinavir-enhancing therapy.
    Middleton T; Smith D; Larder B; Law M; Birch C
    HIV Clin Trials; 2001; 2(6):445-52. PubMed ID: 11742431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiretroviral treatment. HIV infection in adults: better-defined first-line treatment.
    Prescrire Int; 2004 Aug; 13(72):144-50. PubMed ID: 15532140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preventing and managing antiretroviral drug resistance.
    Kuritzkes DR
    AIDS Patient Care STDS; 2004 May; 18(5):259-73. PubMed ID: 15186710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High level of HIV-1 resistance in patients failing long-term first-line antiretroviral therapy in Mali.
    Fofana DB; Soulié C; Baldé A; Lambert-Niclot S; Sylla M; Ait-Arkoub Z; Diallo F; Sangaré B; Cissé M; Maïga IA; Fourati S; Koita O; Calvez V; Marcelin AG; Maïga AI
    J Antimicrob Chemother; 2014 Sep; 69(9):2531-5. PubMed ID: 24855120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The rationale for a study on HIV-1 reverse transcriptase mutations and outcome of antiretroviral therapy with two nucleoside analogs.
    Gianotti N; Moretti F; Tambussi G; Capiluppi B; Ferrari M; Lazzarin A
    J Biol Regul Homeost Agents; 1999; 13(3):158-62. PubMed ID: 10560749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The emergence and epidemiology of resistance in the nucleoside-experienced HIV-infected population.
    Pillay D
    Antivir Ther; 2001; 6 Suppl 3():15-24. PubMed ID: 11678470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug-resistant human immunodefiency virus.
    Kozal MJ
    Clin Microbiol Infect; 2009 Jan; 15 Suppl 1():69-73. PubMed ID: 19220361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Persistence of HIV-1 drug resistance mutations and emergence during antiretroviral treatment interruption: considerations from a clinical case.
    Torti C; Moretti F; Uccelli MC; Tirelli V; Quiros-Roldan E; Gargiulo F; Carosi G
    Med Sci Monit; 2003 Apr; 9(4):CS16-9. PubMed ID: 12709675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiretroviral genotypic resistance in plasma RNA and whole blood DNA in HIV-1 infected patients failing HAART.
    Saracino A; Gianotti N; Marangi M; Cibelli DC; Galli A; Punzi G; Monno L; Lazzarin A; Angarano G;
    J Med Virol; 2008 Oct; 80(10):1695-706. PubMed ID: 18712823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical Outcomes of Virologically-Suppressed Patients with Pre-existing HIV-1 Drug Resistance Mutations Switching to Rilpivirine/Emtricitabine/Tenofovir Disoproxil Fumarate in the SPIRIT Study.
    Porter DP; Toma J; Tan Y; Solberg O; Cai S; Kulkarni R; Andreatta K; Lie Y; Chuck SK; Palella F; Miller MD; White KL
    HIV Clin Trials; 2016 Feb; 17(1):29-37. PubMed ID: 26899540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evolution of HIV-1 genotype in plasma RNA and peripheral blood mononuclear cells proviral DNA after interruption and resumption of antiretroviral therapy.
    Imaz A; Olmo M; Peñaranda M; Gutiérrez F; Romeu J; Larrousse M; Domingo P; Oteo JA; Niubó J; Curto J; Vilallonga C; Masiá M; López-Aldeguer J; Iribarren JA; Podzamczer D;
    Antivir Ther; 2012; 17(3):577-83. PubMed ID: 22301439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Human immunodeficiency virus resistance to antiretroviral drugs].
    Karmochkine M; Descamps D
    Ann Med Interne (Paris); 1999 Dec; 150(8):615-22. PubMed ID: 10686643
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel drug resistance mutations in HIV: recognition and clinical relevance.
    Perno CF; Svicher V; Ceccherini-Silberstein F
    AIDS Rev; 2006; 8(4):179-90. PubMed ID: 17219733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current management challenges in HIV: antiretroviral resistance.
    Kuritzkes DR; Boyle BA; Gallant JE; Squires KE; Zolopa A
    AIDS Read; 2003 Mar; 13(3):133-5, 138-42. PubMed ID: 12728868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Your next nightmare: 28% of new HIV cases may be drug-resistant.
    AIDS Alert; 1999 Dec; 14(12):133-7. PubMed ID: 11366987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.